Recurrent Laryngeal Neuropathy (RLN) is a highly prevalent and predominantly left-sided, degenerative disorder of the recurrent laryngeal nerves (RLn) of tall horses, that causes inspiratory stridor at exercise because of intrinsic laryngeal muscle paresis. The associated laryngeal dysfunction and exercise intolerance in athletic horses commonly leads to surgical intervention, retirement or euthanasia with associated financial and welfare implications. Despite speculation, there is a lack of consensus and conflicting evidence supporting the primary classification of RLN, as either a distal ("dying back") axonopathy or as a primary myelinopathy and as either a (bilateral) mononeuropathy or a polyneuropathy; this uncertainty hinders etiological and pathophysiological research. In this review, we discuss the neuropathological changes and electrophysiological deficits reported in the RLn of affected horses, and the evidence for correct classification of the disorder.
| IN TR ODUC TION
Recurrent laryngeal neuropathy (RLN), is an equine degenerative disorder of the recurrent laryngeal nerves (RLn) of (particularly) tall breeds such as Thoroughbreds and Drafts. 1, 2 The disease is characterized by preferential degeneration of the left RLn over the right RLn 3,4 that causes paresis or, in severe cases, paralysis of the left intrinsic laryngeal muscles preventing arytenoid movement, which is vital for enabling unimpeded inspiratory airflow. Recurrent laryngeal neuropathy (RLN) is performance limiting in horses performing at their greatest exertion, in particular, in racehorses. 5 Many studies have identified RLN-associated neuropathological changes in both RLns (left more so than right) in clinically unaffected horses, leading authors to postulate whether the majority of unaffected horses are in fact subclinical cases. 3, 4, 6, 7 The mechanisms that lead to the varying severity (from subclinical to severe) in horses are largely unknown, however, the identification of many subclinical cases means that case selection for "unaffected" controls for research is challenging. Amongst the apparent risk factors, horse height is reported as a significant contributor to RLN-status, with taller horses being at greater risk 1, 2 ; it is unclear whether height itself is the principal risk factor or simply a covariate for nerve length. Males are more commonly affected than females. 2, 8 Genetic risk factors are plausible given that the heritability of RLN ranges from 8 to 40%
depending on the breed affected 9, 10 ; however, as of yet no specific risk alleles have been reported despite many published studies. 1, 11, 12 Indeed, very little is known about the cause of RLN 13 : the array of etiologies proposed includes mechanical stress 14 or ischemic nerve damage, 4 pressure damage, 4 an infectious etiology, 13 vitamin deficiencies, 15 and toxic insults. [16] [17] [18] [19] RLN is consistently described as a peripheral neuropathy but without a more detailed classification describing the primary defect. 20, 21 Conflicting data is available supporting RLN as affecting just the RLn (ie, a mononeuropathy) or whether it affects other peripheral nerves (a polyneuropathy). 3, 4, 7, 20, [22] [23] [24] Also unanswered is whether the degeneration begins within the axon or the myelin sheath. Providing answers to these key questions would likely expedite the search for the etiology, and potential therapies by helping focus research. For instance, molecular therapies are in development for similar human peripheral neuropathies, such as the group of peripheral neuropathies known as the Charcot-Marie-Tooth (CMT) diseases 25 but a key element to developing these therapies is the understanding of where the degeneration begins (ie, in the nerve cell body, axon, synapse, myelin sheath or glia), to enable focused treatment. Potential issues that have hindered research in these areas for RLN include the selection of adequate control groups (as outlined previously), the trend for studies to evaluate subjective histopathological features in unblinded, uncontrolled fashion and that many RLN-studies are typically statistically unpowered.
This review article discusses the current literature (veterinary and human) pertaining to the pathophysiology underlying RLN, addressing the issues relating to characterizing RLN as an axon-versus myelinopathy and a mononeuropathy or polyneuropathy.
| EQU I N E RL n
The RLn contains the longest motor axons in the horse, measuring up to 2.5 m in length in Draft and Thoroughbred horses, with the left nerve being 30 cm longer than the right in tall breeds 6 ( Figure 1 ).
Their cell bodies are situated within the nucleus ambiguus in the brainstem and they project their axons caudally within the vagus nerves before RLn fibers exit and, on the left, traverse medially around the aorta and on the right, medially around the right subclavian artery. 26 The nerves then follow an identical bilateral course, moving rostrally, adjacent to, and on either side of the trachea and carotid arteries. Their long axonal course is established during embryonic development: in the growing embryo, the RLn branch from the vagus nerve at the level of the sixth aortic arch, whereby they innervate the developing intrinsic laryngeal muscles. As the neck of the embryo elongates, the larynx migrates rostrally (relative to the aortic arches) resulting in elongation of the RLn axons as they are held distally by the aortic arches. 27 At the level of the aorta, the equine RLn is 1.5 mm in diameter and the epineurium contains between 6 and 29 perineuronal bundles (fascicles),
(generally between 11 and 15; Figure 2 ). 28 Several authors have FIG URE 1 Anatomical representation of the dorsal view of the course taken by the RLn (yellow) in the horse, including both vagosympathetic trunks, vagus nerves, and important vasculature. Both RLn originate in the medulla oblongata where their cell bodies are located within the nucleus ambiguus. The left RLn courses around the aortic arch before innervating the muscles of the larynx and the right RLn courses around the right subclavian artery before it courses rostrally FIGURE 2 Schematic representative of a peripheral nerve. The main connective tissue structures include the epineurium (surrounding the entire nerve), the perineurium (surrounding each fascicle within the nerve) and the endoneurium (located around an individual axon). The perineurium also contains blood vessels and lymphatics reported structural variations at the hairpin turn of the left RLn, as it courses around the aorta (eg, Haslam's Anomaly and Renaut bodies) although these appear with the same frequency in horses with and without RLN. 4, [28] [29] [30] The RLn provide general somatic efferent innervation to the laryngeal and cranial esophageal muscles 26, 31 and are comprised of wide diameter, alpha, myelinated nerve fibers of 12-20 mm diameter. 28 Interspersed between the large myelinated fibers are less numerous, narrower myelinated fibers (that are speculated to be beta and gamma fibers) and small unmyelinated fibers. 26 A study of 9 mixed-breed horses under 2 years old with no evidence of laryngeal disease, revealed that the total number of myelinated fibers, mean fiber diameter and percentage of fibers over 9.5 lm in diameter were significantly lower in the left RLn compared with the right (p < 0.05). 32 In other species where greater numbers of myelinated nerve fibers have been reported in the right RLn compared with the left (humans, dog, and cats) typically the myelinated nerve fiber diameter is larger in the left RLn, which is believed to compensate for the greater length of the left RLn, thus maintaining comparable conduction properties since wider axons have faster conduction speeds. [33] [34] [35] [36] [37] Unequal fiber numbers are not found in all species: indeed equal (or near equal) fiber numbers have also been reported in humans, rats, and giraffes. 37, 38 The greater numbers of myelinated fibers in the right RLn might reflect the presence of afferent (sensory) fibers, however the presence of sensory axons within equine RLn has not been investigated. In humans, these sensory axons receive input from the mucosa in the region of the vocal folds, and in cats, the pharyngeal swallow reflex occurs in part, from esophageal pressure increases transmitted through the RLn. 39 However, staining for afferent branches in the rat RLn did not show any sensory branches 40 suggesting that there are species differences in RLn-associated sensory pathways.
| The importance of the classification of neuropathies
Historically, human peripheral neuropathies were classified according to the site of the primary pathology-as a myelinopathy or axonopathy -caused by degeneration of the myelin sheath or axon respectively, and by the type of neuron affected: sensory or motor. 41 In addition, the involvement of a single nerve or many different nerves in the disease process is described as a mononeuropathy or polyneuropathy, respectively. 41 These classifications were critical for accurate diagnoses, and they underpinned all investigations into the diseases' etiopathogenesis. However, with advanced genomics, many inherited neuropathies are now classified by their causative genetic mutations.
The genetic era has highlighted that a single disease phenotype can result from mutations in different genes, and further, that subtle differences in a disease phenotype can be explained by different mutations within the same gene.
The characterization of a peripheral neuropathy as either an axonopathy or a myelinopathy is achieved by amalgamating data from nerve conduction velocity (NCV) testing, pathological observations (from nerve biopsy specimen or postmortem examination) and genetic studies. [42] [43] [44] Nerve conduction velocities (NCVs) are markedly slowed when there is extensive demyelination, and normal to partially slowed, with reduced compound muscle or sensory action potentials, in an axonopathy. 42 In the diagnosis of human CMT disorders, genetic testing has largely superseded nerve biopsy 43 : when a causative genetic mutation is found, differentiating an axonopathy from a myelinopathy is simplified by the mutated protein's normal localized expression.
However, mutation of an axonally localized protein can lead to a disease phenotype typically attributed to a myelinopathy and vice versa (see below). As a genetic cause of RLN has not yet been identified, the disease's classification as an axonopathy or myelinopathy can only be based on pathological and electrophysiological studies.
| Charcot Marie tooth disease complex
The CMT diseases are inherited human peripheral polyneuropathies that affect either sensory or motor axons, or both, and are arranged into categories depending upon their primary site of pathology. 43 Where possible, a definitive diagnosis of a specific form of CMT is made after genetic testing, however where a mutation is not found, pathological classifications provide the framework for the diagnosis and importantly, prognostic information. episode. 41 Repeated demyelination/remyelination is most commonly reported in primary myelinopathies 41 but does occur in primary axonopathies, (whence they are termed pseudo-onion bulbs). 63, 64 Segmental demyelination/remyelination manifests as inconsistent internodal lengths and myelin thicknesses, typically within the same fiber, and is a common feature of CMT type 1 (demyelinating form). 41, 58, 60 However, segmental myelin loss also occurs secondarily in primary axonopathies when there is loss of communication with the axon terminal 65, 66 ; this is a key feature of RLN.
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As both onion bulbs and segmental demyelination/remyelination can occur with either primary myelinopathies or axonopathies, clues as to the primary site of degeneration might be evident from other associated localized pathological changes. In subclinical RLN cases, onion bulbs and regions of demyelination/remyelination occur most commonly at prominent sites of axonal histopathological change. 3, 53 This is consistent with secondary demyelination that occurs as a direct result of axonal degeneration. 41 These axonal histopathological changes included paranodal axoplasmic outpouchings (see below), 53 organelle accumulations within swollen axons and active axonal degeneration at sites of onion bulb formation. 3, 7 Specifically, Cahill and Goulden lin. 53 The paranode is the main anchorage point of the myelin lamellae to the axon, and mechanical myelin slippage is a well-recognized consequence of paranodal pathology. [67] [68] [69] When sural nerve biopsy specimen from human patients with a demyelinating polyneuropathy were compared to those with a primary axonal polyneuropathy (diagnosed on electrophysiological tests), there was no difference in the number of onion bulbs between the two conditions. 64 The authors explained the lack of difference in onion bulb numbers resulted from the fact that onion bulbs identified in patients with the primary axonopathy had been misclassified: they were instead, pseudo-onion bulbs resulting from axonal degeneration/regeneration. 66 The differentiation of pseudo-onions bulbs from onions bulbs can be difficult, and is typically made by an experienced pathologist who will assimilate the clinical history, results from other diagnostic tests and the type and distribution of the pathology present in a nerve biopsy specimen (sometimes with electron microscopy [EM] and immunohistochemistry); where the concentric Schwann cell processes mainly contain axons or axonal sprouts, this is more indicative of axonal degeneration and regeneration, and these Schwann cell processes are therefore termed pseudo-onion bulbs. 70 As Bosboom et al 64 shows, correctly classifying these Schwann Cell proliferations as onion bulbs or as pseudo-onions relies on knowing the underlying pathological process at work, so it is entirely feasible that the demyelination/remyelination reported in RLN results from axonal pathology and not primary demyelination.
Defining the primary site of disease pathology is likely harder in end-stage disease tissue; study of tissue from individuals early in the disease course to identify active pathological processes might be more informative. In the RLn from subclinical cases (equivalent to grade II-
) organelle accumulations were seen in the paranodes ( Figure 4) and along some internodal regions 3, 4, 7, 53 in the most distal 40 cm of the left RLn and became more numerous in the most distal regions; they were only found in the distal 10 cm of the right RLn. The majority of the paranodal swellings were located proximal to the nearest Node of Ranvier. These swellings were further identified as axoplasmic evaginations that protruded into the myelin sheath, containing mitochondria (normal and degenerate) and dense lamellar bodies (lysosomes). 53 Distal to the swellings, the neurofilaments aggregated at the axon center, causing the mitochondria to be displaced peripherally. Duncan and Hammang 53 hypothesized that deficits in axonal transport were most likely the cause of the paranodal evaginations, as they occurred at the bracelet of Nageotte, the site of myelin attachment at the paranode which is a point of axolemmal weakness; they speculated that if axonal transportation is perturbed, cargo will accumulate and cause bulging of the axolemma at its weakest point. 71 Axonal transportation deficits are typically seen in primary axonopathies; in particular, certain forms of CMT type 2 (2a, 2e, 2f) all exhibit transportation deficits whereas different forms of CMT type 1 (myelinopathies) do not (reviewed by Millecamps and Julien 72 ).
Further evidence that these paranodal evaginations result from pathology arising in the axon can be found when looking for their replication in other diseases. Duncan and Hammang 53 commented that the paranodal evaginations appear to be a hallmark of RLN; however, they are almost identically replicated in certain toxic polyneuropathies (acrylamide and 2,5-hexane-diol) and were also identified in a rat neuroma study. [73] [74] [75] [76] Acrylamide-and hexane-associated polyneuropathies share many other similarities to RLN. They both cause a "dying-back" central-peripheral neuropathy, preferentially affecting long motor neurons. 77, 78 Pathological studies of these toxic neuropathies identified mitochondria (and neurofilaments) located within the paranodal evaginations, typically located proximal to the node. 79 In addition the evaginations precede classical signs of axonal degeneration in acute models of intoxication. 71, 74, 76, 80 Axonal paranodal evaginations were also detected in the proximal sciatic nerve axons of rats, 1 month after the formation of a neuroma, after crushing and ligation. 76 The evaginations contained similar membrane-bound organelles and dense laminar bodies seen in subclinical RLN cases and in neurons from acrylamide-or hexane-treated animals 53, 71, 73, 74, 80 ; they were most numerous in the large myelinated fibers. 41 These findings suggest that loss of trophic support from the muscle could be another important factor leading to generation of these paranodal evaginations, 76 or it could simply reflect that disruption to both anterograde and retrograde axonal transportation systems can cause evagination.
Other histopathological features reported to occur in the RLn of subclinical RLN cases are axonal spheroids and axonal atrophy though they have not been quantified. 3, 4, 7, 53 Axonal spheroids are the hallmark pathological sign of axonal dystrophy, a process that is distinct from axonal degeneration, and associated with synaptic dysplasia, abnormal axonal regeneration, or an imbalance with axonal transportation. 87, 88 The timing of axonal spheroid development can serve as a clue for a primary (before degeneration signs occurring) versus a secondary (development of endbulbs after degeneration) axonal transportation deficit. 89 End-bulb formation (where the axon terminal swells) has not been reported specifically in RLN, and with the reported paranodal swellings, it is likely that axonal transportation deficits arise in the RLn (left more than right) before the loss of axonal integrity. Axonal atrophy is detectable in end-stage axonal degeneration of various types. 41 These pathological changes, although associated with many different etiologies, are all interpreted as an axonal pathology, supporting primary axon degeneration in RLN.
| A XON A L D E GE NE RA TI ON
For many years, axonal degeneration, studied in humans and mice, was thought simply to encompass Wallerian degeneration and apoptosis via two separate pathways. Wallerian degeneration is seen in the axon distal to a site of injury and involves activation of calpain, resulting from increased axonal calcium influx that leads to orderly degradation of the cytoskeleton and membrane proteins. 90 The influx of calcium is hypothesized to result from the reversed action of the Na Although two key elements in this pathway of axonal degeneration (SARM1 and NMNAT2) have been identified (Figure 5 ), their exact actions are, as yet, unknown. It will be crucial to identify diseasespecific degeneration pathways associated with distal axon loss to ensure that targeted, efficacious therapies can be developed in RLN.
| Bilateral mononeuropathy or polyneuropathy?
When the severity of RLN is sufficient to cause clinical signs, the typical neuropathological changes identifiable in the left RLn, are also detected (with less severity) in the right 6, 20, 23, 55, 56, 113, 114 ; a disparity that has been explained by the right RLn's shorter length compared with that of the left. 21 20, 115, 116 ). However, these pathological studies confirm the disorder's bilateral occurrence and reveal that the disorder cannot solely be explained by the physical course of the left RLn.
Bilateral degeneration of one pair of peripheral nerves has been reported in humans as a component of the mononeuropathy multiplex syndrome (defined as the isolated and differential involvement of separate nerves) often because of a generalized systemic disorder and most commonly diabetes mellitus. 117 Signs of nerve dysfunction relate to the specific nerve affected: frequently they are initially asymmetrical, but they progress to symmetrical nerve dysfunction and then to other nerve groups. 41, 117 This suggests that systemic disorders (at least initially) can have localized nerve involvement. Indeed, length dependency is a common feature of many peripheral nerve disorders with a genetic basis: even though defective protein expression is a generalized feature, the signs are most readily apparent in the longest nerves. 60, 118 In humans, the longest nerves are to the distal extremities and length dependency is revealed by many of the CMT disorders that have distal sensory loss, or distal neurogenic muscle atrophy (leading to pes cavus deformity). 60, 118 Length dependency is also a feature of some acquired neuropathies such as diabetic neuropathy (reviewed by Kazamel and Dyck 119 ).
Determining whether this equine neuropathy affects only the RLn or in addition, other long nerves, has been a key objective in several studies over past decades 3, 6, 7, 20, 23, 113 In contrast, several reports detail the possible significance of RLNassociated pathological features in other long, nonlaryngeal nerves. 3, 7, 23 Indeed, Duncan et al (14 years after their study described above) examined the deep peroneal nerves of 14 male Draft horse foals, reporting the presence of B€ ungner bands and onion bulbs in nerves from 6 month old foals. 24 The authors made no comment about clinical signs associated with peroneal nerve dysfunction being present in any foal, nor was there any investigation into pathological changes within the peroneal nerve-innervated muscles. 54 Cahill and Goulden examined Some authors have additionally, or instead, searched for histopathological, neuropathic changes in selected limb muscles because RLNassociated intrinsic laryngeal muscle pathology is readily identified.
20,56
Cahill and Goulden 56 found no significant histopathological changes in the tibialis cranialis, gastrocnemius or biceps femoris muscles of 4 horses with clinically relevant RLN. In contrast, presumed neurogenic muscle fiber atrophy was detected in the EDL muscle of 3 of the 4 horses, although in only one of these animals was the key feature of neuronal regeneration (seen in RLN), known as fiber type grouping detected. 56 It is noteworthy that these apparent EDL muscle changes occurred despite the lack of nerve pathological changes in previous studies of the deep peroneal nerve by the same and other authors 3, 23, 56 suggesting either that muscle histopathological assessment for neurogenic change has greater sensitivity than nerve histology, or that the detected muscle changes were not neurogenic in origin.
Conflicting results obtained by these various groups and between examination of nerves and muscles, reveal the problems associated with unblinded, uncontrolled, subjective histopathological assessment. In particular, including greater numbers of height-, sex-, and breed-matched control horses would have enabled more robust conclusions to be drawn, given that each is associated with RLN development. Since spheroid formation is seen with aging, the apparent increased spheroidal numbers in the diseased groups could be explained by the lack of age matching between the control and diseased groups: the horses in the control group were all <3 years old, whereas the diseased group's horses ranged from 2 to 22 years old. 135 Perhaps then, RLN represents the localized involvement of two nerves (the left and right RLn) associated with a systemic disorder that has subclinical involvement of other long nerves in only a few (eg, the most severely affected, or tallest) horses. Unfortunately, despite the previous work, no clear conclusion regarding the possible involvement of other nerves in RLN can be made. In particular, the trend for studies to evaluate subjective histopathological features in unblinded, uncontrolled fashion and with low power, means that this crucial question remains unanswered such that RLN cannot yet be defined as bilateral mononeuropathy or a polyneuropathy with certainty.
| OBJ E CTI V E F U N CTI ON A L T ESTI N G OF TH E R L n
Nerve function testing for a suspected neuropathy helps define each tested nerve's involvement but also the type of pathology (axonal or myelin-based). 44 Function is assessed either directly, by examining the speed of conduction (NCV) or, indirectly, via the measure of latency (delay from nerve stimulation to muscle contraction) and through functionality of the innervated structure (ie, the larynx in RLN 144 The negative correlation between height and NCV has been attributed to the abrupt tapering of the nerve fiber diameter with increasing nerve length (which is mainly caused by a reduction in the axonal diameter) rather than to any effect on internodal distance. [145] [146] [147] Likely, because of practical constraints, very few researchers have . 139 However, no correction was made for differences in nerve length in our study, which likely explains the longer latency of the left RLn. Nevertheless, the similar left and right RLn conduction latencies reported in dogs and humans 144, 148 were explained by the left side's wider diameter (and therefore faster conducting) axons when compared to the right, compensating for the longer path. 37 The left distal RLn of young (<2 year old) horses that lacked histopathological features of RLN, had significantly fewer myelinated nerve fibers, and smaller diameter myelinated nerve fibers than those in the right distal RLn. Furthermore, the proportion of the widest myelinated fibers (>9.5 lm) was also always lower in the left RLn compared with the right. 149 These findings imply that the equine RLn and their NCVs are unusual.
Nerve conduction velocities (NCVs) in the left and right RLn of horses have been shown to differ between the two nerves in several studies;
this has been recapitulated in normal ponies and horses, as well as in RLN cases. 113, [137] [138] [139] 150 The interpretation of this finding differs between authors: is RLN simply ubiquitous or does it result from deterioration of 'normal' equine anatomy?
Despite this previous research, the correct classification of RLN's primary basis based on objective electrophysiological recordings remains unclear. This might largely because of differences between methodologies, low numbers of animals, and differences in signalment in the animals examined. It also very likely relates to the practical difficulties encountered when performing these sorts of tests in horses.
| CON CL USI ONS
The majority of the histopathological changes (B€ ungner bands, regenerating clusters, paranodal evaginations, and spheroids) reported in RLNaffected horses are associated with primary axonal dysfunction. 3, 4, 6, 7, 20, 30, 52, 53, 113, 114 Further, we have discussed how pathological features traditionally associated with primary myelinopathies (ie, onion bulbs and demyelination and remyelination) also occur in primary axonopathies. In RLN, these histopathological changes occur simultaneously with other pathological features that are exclusively reported in axonopathies such as paranodal evaginations (that occur in toxic axonopathies and axotomies) and at sites of axonal degeneration. 4, 53 In addition, we have highlighted evidence that suggests axonal transportation deficits might play a role in the etiopathogenesis of RLN.
While there is compelling evidence that RLN affects both the left and (to a lesser extent) right RLn, it is not yet clear whether in some horses, other long nerves are also affected. There is some pathological evidence to suggest subclinical involvement of other long peripheral nerves in cases of RLN (B€ ungner bands, and onion bulbs in nonlaryngeal peripheral nerves), 3, 4, 7, 20, 23, 24 nevertheless these findings are not found in all studies; typically, and unfortunately, most of these studies suffer from the limitations discussed throughout this review article and a comprehensive, objective, blinded study that evaluates other long peripheral nerves, and long spinal tracts of the CNS, with age, height, breed, and sex matched controls is required.
In summary, in our opinion RLN is best currently classified as a distal axonopathy with clear evidence of involvement of both RLn. Further, from a functional and clinical perspective, this disease can best be regarded as a mononeuropathy of the left RLn: however, when considering the etiology and pathophysiology of this disorder, there is insufficient evidence to classify the disease as either a bilateral mononeuropathy or polyneuropathy, a classification that remains fundamentally important for the study of this enigmatic, and highly prevalent equine neurodegenerative disease. CSS_01735.
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